1. Home
  2. CGTX vs WHG Comparison

CGTX vs WHG Comparison

Compare CGTX & WHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • WHG
  • Stock Information
  • Founded
  • CGTX 2007
  • WHG 1983
  • Country
  • CGTX United States
  • WHG United States
  • Employees
  • CGTX N/A
  • WHG N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • WHG Investment Managers
  • Sector
  • CGTX Health Care
  • WHG Finance
  • Exchange
  • CGTX Nasdaq
  • WHG Nasdaq
  • Market Cap
  • CGTX 158.8M
  • WHG 157.9M
  • IPO Year
  • CGTX 2021
  • WHG 2002
  • Fundamental
  • Price
  • CGTX $1.66
  • WHG $16.71
  • Analyst Decision
  • CGTX Strong Buy
  • WHG
  • Analyst Count
  • CGTX 3
  • WHG 0
  • Target Price
  • CGTX $2.83
  • WHG N/A
  • AVG Volume (30 Days)
  • CGTX 1.3M
  • WHG 7.6K
  • Earning Date
  • CGTX 11-06-2025
  • WHG 10-30-2025
  • Dividend Yield
  • CGTX N/A
  • WHG 3.59%
  • EPS Growth
  • CGTX N/A
  • WHG 154.57
  • EPS
  • CGTX N/A
  • WHG 0.82
  • Revenue
  • CGTX N/A
  • WHG $96,243,000.00
  • Revenue This Year
  • CGTX N/A
  • WHG N/A
  • Revenue Next Year
  • CGTX N/A
  • WHG N/A
  • P/E Ratio
  • CGTX N/A
  • WHG $20.27
  • Revenue Growth
  • CGTX N/A
  • WHG 4.20
  • 52 Week Low
  • CGTX $0.22
  • WHG $13.49
  • 52 Week High
  • CGTX $3.83
  • WHG $18.97
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 48.96
  • WHG 53.96
  • Support Level
  • CGTX $1.54
  • WHG $16.14
  • Resistance Level
  • CGTX $1.77
  • WHG $17.00
  • Average True Range (ATR)
  • CGTX 0.13
  • WHG 0.30
  • MACD
  • CGTX -0.01
  • WHG 0.07
  • Stochastic Oscillator
  • CGTX 31.49
  • WHG 80.23

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: